Overview

A Double-blind, Placebo-controlled Trial of Donepezil Adjunctive Treatment for Cognitive Impairment in Schizophrenia

Status:
Unknown status

Trial end date:
2012-06-01

Target enrollment:

Participant gender:

Summary

The objective of the study was to study the effects of donepezil on cognition in patients with schizophrenia. The investigators conducted a 12-week, double-blind, placebo-controlled trial of donepezil as adjunctive treatment to antipsychotic drugs on patients with schizophrenia.

Phase:

Phase 4

Details

Lead Sponsor:

Central South University

Treatments:

Donepezil